Renin-angiotensin system inhibition after surgical aortic valve replacement for aortic stenosis.

Andreas MartinssonCharlotta TörngrenSusanne J NielsenEmily PanEmma C HanssonAmar TahaAnders Jeppsson

Published in: Heart (British Cardiac Society) (2023)

The results of this study suggest that medical therapy with an RAS inhibitor after SAVR is associated with a 13% lower risk of MACE and a 21% lower risk of all-cause death.

Keyphrases

aortic valve replacement
aortic stenosis
transcatheter aortic valve replacement
transcatheter aortic valve implantation
ejection fraction
aortic valve
left ventricular
coronary artery disease
healthcare
stem cells
heart failure
wild type